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Chagas disease (CD), caused by the protozoan parasite Trypanosoma cruzi, is
considered a neglected tropical disease by the World Health Organization. Congenital
transmission of CD is an increasingly relevant public health problem. It progressively
becomes the main transmission route over others and can occur in both endemic and
non-endemic countries. Though most congenitally infected newborns are asymptomatic
at birth, they display higher frequencies of prematurity, low birth weight, and lower
Apgar scores compared to uninfected ones, and some suffer from severe symptoms.
If not diagnosed and treated, infected newborns are at risk of developing disabling
and life-threatening chronic pathologies later in life. The success or failure of congenital
transmission depends on interactions between the parasite, the placenta, the mother,
and the fetus. We review and discuss here the current knowledge about these
parameters, including parasite virulence factors such as exovesicles, placental tropism,
potential placental defense mechanisms, the placental transcriptome of infected
women, gene polymorphism, and the maternal and fetal/neonatal immune responses,
that might modulate the risk of T. cruzi congenital transmission.
Keywords: Trypanosoma cruzi, infection, maternal-fetal interactions, placenta, congenital chagas disease
CHAGAS DISEASE
Trypanosoma cruzi, a protozoan parasite, is the etiological agent of CD, a neglected tropical disease
(WHO, 2015; Lenk et al., 2018) endemic to Latin American countries. Affected countries extend
from the United States to Argentina and Chile (Pérez-Molina and Molina, 2018). The parasite is
primarily transmitted by insect vectors, but can also be transmitted through blood transfusion,
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organ transplantation, consumption of parasite-contaminated
food, and vertically from mother to child. In Latin America, CD
is an important cause of cardiovascular morbidity and premature
death (Rassi et al., 2012; WHO, 2015).
The disease evolves in two phases. The acute phase, defined
by high parasitemia, lasts 2–3 months. It is often asymptomatic
or involves non-specific flu-like symptoms. However, 2–12%
of the infected individuals, mostly children under 3 years,
die from acute myocardiopathy at times associated with a
meningoencephalic compromise (Carlier and Truyens, 2015).
The immune response eliminates most but not all parasites.
As a consequence, the individual enters the chronic phase and
remains infected for the rest of their lives. Although most
patients remain asymptomatic for periods ranging in length from
several months to decades, 30 – 40% of the infected people
develop cardiac (mostly) and/or digestive tract (less frequent)
pathologies that may lead to premature death (Rassi et al., 2012;
de Oliveira et al., 2018).
CONGENITAL CHAGAS DISEASE
Most women of gestational age are chronically infected, having
acquired the infection during infancy. Around 5% of them
transmit the parasite to their fetus, and thus approximately 9000
newborns infected with CD in Latin America are born every
year. Cases of congenital CD have also been reported outside of
the naturally endemic area (WHO, 2015; Antinori et al., 2017).
Congenital infection is gaining importance as a route of T. cruzi
transmission in endemic countries, due to control programs
of vectorial and transfusional transmission routes, and is now
estimated to account for 22% of new cases (WHO, 2015; Picado
et al., 2018). In non-endemic countries, most of the new cases
result from congenital transmission (Howard et al., 2014; WHO,
2015). Importantly, since T. cruzi maternal-fetal transmission can
be repeated at each pregnancy and observed from one generation
to another, this way of transmission can easily expand in time
(Messenger et al., 2017).
Congenital CD is characteristically an acute parasite infection.
Though most (around 60%) congenitally infected newborns
are asymptomatic at birth, they display higher frequencies
of low birth weight, prematurity, and lower Apgar scores at
birth compared to uninfected newborns, while some infected
newborns suffer from severe symptoms that can rapidly lead
to death (Torrico et al., 2004; Liempi et al., 2016). Moreover,
congenitally infected infants are at risk of disabling and life-
threatening chronic pathologies later in life (Cardoso et al., 2012;
Requena-Méndez et al., 2014; Carlier et al., 2015; Antinori et al.,
2017). It is therefore essential to prevent congenital transmission
and to rapidly diagnose and treat congenitally infected newborns.
Importantly, the occurrence of congenital transmission
depends on interactions between T. cruzi, the placenta, the
maternal immune system, and the developing fetal/neonatal
immune response (Carlier and Truyens, 2015; Liempi et al.,
2016). Here we will discuss the factors mentioned above
that modulate the risk and probability of T. cruzi maternal-
fetal transmission.
THE PARASITE DIVERSITY
Trypanosoma cruzi belongs to the Kinetoplastida order,
Trypanosomatidae family and presents a complex life cycle
involving invertebrate triatomine hosts. Four main cellular forms
can be identified during its life cycle: (i) the blood trypomastigote
is the infective extracellular non-replicative form of the parasite,
which is found in the bloodstream of the mammalian host, (ii)
the metacyclic trypomastigote, also non-replicative, is present
in the terminal portion of the digestive and urinary tracts of the
vectors, (iii) the epimastigote is the replicative extracellular form
of the parasite present in the triatomin insect vector, and (iv) the
amastigote is the intracellular replicative form of the parasite in
the vertebrate host (Rodrigues et al., 2014).
Trypanosoma cruzi is a paradigmatic case of predominantly
clonal evolution (Tibayrenc et al., 1986) with “unequivocal
evidence of genetic recombination” (Gaunt et al., 2003). Actually,
the different known strains and clones of the parasite are classified
into seven discrete typing units (DTUs), that are defined as a “sets
of stocks that are genetically closer to each other than to any
other stock and are identifiable by common molecular, genetic,
biochemical, or immunological markers” (Tibayrenc, 1998). The
DTUs ranged from T. cruzi I to T. cruzi VI, and lately, T. cruzi
bat was also added (Zingales et al., 2012; Lima et al., 2015).
Parasites from these DTUs are distributed differentially among
insect and mammalian host species and therefore lives in different
geographical areas (Zingales et al., 2012; Brenière et al., 2016).
All T. cruzi parasites, regardless of the DTUs or where they
belong, can cause CD. However, epidemiological studies suggest
that T. cruzi I is associated with anthroponotic as well as sylvatic
environments. On the other hand, T. cruzi II, V, and VI are
mainly related to human environments and particularly chronic
CD patients contrarily to T. cruzi III and IV which are found to
be present in sylvatic habitats (Yeo et al., 2005). An association
between DTUs and clinical outcomes is suspected (Messenger
et al., 2015). These host and geographic specificities have been
proposed to determine the probability of transmission and are
related to the pathogenesis of CD. Parasites belonging to diverse
DTUs have different biological properties, including growth rates
in cultures, tropisms to tissue and organs, antigenicity, capacity
to infect potential insect vectors, drug susceptibility, number
of chromosomes, and DNA content (Macedo and Pena, 1998;
Macedo et al., 2004). Characterization of the gene content and
genome architecture of T. cruzi, as well as a whole-organism
proteomic analysis of its four life cycle stages, has been reported
(El-Sayed et al., 2005). Further, comparative genomics of different
strains using different sequencing strategies and technologies
provide data for the identification of genes associated with host
tropism, pathogenicity, and modes of transmission (Berná et al.,
2018; Callejas-Hernández et al., 2018; Reis-Cunha et al., 2018).
Whether all T. cruzi DTUs can be congenitally transmitted
in utero is a matter of debate. There is presently no clear
evidence that particular T. cruzi DTUs, as defined by the
currently used molecular markers, would preferentially be
transmitted congenitally [reviewed in Carlier and Truyens
(2015), Truyens and Carlier (2017)]. We however, recently
observed that congenital transmissions in Argentina and Mexico
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were associated with a maternal portage of “non-TcI” parasites
(we did not detect congenital cases harboring TcI DTU) (Buekens
et al., 2018). Concordantly, higher congenital transmission rates
were reported in Brazilian regions where T. cruzi DTU V
predominantly circulates as compared to a country where Tc II
predominates (Luquetti et al., 2015).
PARASITE TROPISM FOR PLACENTA
Tissue tropism to the placenta of different T. cruzi strains has
been described previously, particularly in the murine model
(Andrade, 1982). T. cruzi I (Colombiana strain) parasites present
a high incidence of placental parasitism (98%) compared to
T. cruzi II (Y strain) parasites that only infect 17% of the
placentas. The same strains also present differences regarding
the localization of the amastigotes in the placenta; only the
Colombian strain could be observed consistently in the vascular
part of the placenta. In a more recent work, chronic infected mice
with two different T. cruzi strains, one obtained from a congenital
CD patient [VD: Tc VI (Risso et al., 2004)] and the other one
previously characterized as non-transmissible in mice [K98,Tc I
(Solana et al., 2002)] showed, by means of DNA amplification
and 18s ribosomal RNA expression studies, that VD displayed
stronger placental tropism and lower parasitic loads in peripheral
blood than the K98 strain (Juiz et al., 2017). On the other
hand, female mice infected with the K98 strain present higher
parasitemia than the ones infected with the RA strain (DTU VI).
However, in RA infected females, the infected mice produced
parasite-infected newborns, while K98 did not.
We also showed recently in human placental explants (HPE),
as well as in a placenta-derived epithelial cell line (BeWo),
that VD parasites present a higher infection capacity compared
to the Y strain (Medina et al., 2018). These studies suggest
that the parasite genotype plays a role in tissue tropism




The persistence of T. cruzi parasites at a low level within specific
tissues causes chronic pathogenic inflammation in some patients.
How T. cruzi manages to persist and what factors released by the
parasite influence its dynamics in tissue during chronic infection,
remains poorly known (Teixeira et al., 2011). Nearly all cells can
release extracellular vesicles, or exovesicles (EVs), which have
been recognized as a mode of communication between cells. EVs
may also participate in pathogenic processes (van Niel et al.,
2006; Trocoli Torrecilhas et al., 2009; Cestari et al., 2012; de
Pablos Torró et al., 2018). EVs are small membrane vesicles
that are classified according to size, biogenesis, and composition,
into exosomes and microvesicles (MVs). Exosomes, of 30 to
100 nm in size, are of endocytic origin, have a lipid bilayer,
and are released into the extracellular compartment through
the fusion of the multivesicular body (MVB) with the plasma
membrane of the cell (Raposo and Stoorvogel, 2013). MVs are
also referred to as ectosomes; are more heterogeneous in shape;
and can vary between 100 and 300 nm in diameter. They are
released as a result of the evagination toward the extracellular
space from the plasma membrane. EVs differ not only in origin
and size but also in lipid and protein composition. They have
been identified in all biological fluids (Villagrasa et al., 2014),
and their functions include intercellular communication, host-
pathogen interactions, as well as the modulation of the immune
response against infectious diseases or afflictions such as cancer
(Schorey and Bhatnagar, 2008; Webber et al., 2015). We recently
published reviews on the existence of EVs in protozoa and
parasitic helminths and on the role of T. cruzi EVs (Marcilla
et al., 2014; de Pablos Torró et al., 2018). Moreover, the induction
of physiological modifications in cells by EVs derived from
T. cruzi trypomastigotes has been recently demonstrated. These
alterations involve the blocking of the cell cycle of the host cell,
the permeabilization of the cells, and the disorganization of the
cytoskeleton, among others (Retana Moreira et al., 2019).
EVs in T. cruzi were first described in 1970 (da Silveira
et al., 1979) and found to be rich in glycoconjugates.
Surface glycoconjugates are formed from glycoproteins
(mucins) (de Lederkremer and Colli, 1995; Acosta-Serrano
et al., 2001; Buscaglia et al., 2006; Mendonça-Previato
et al., 2013), glycolipids (lipopeptidophosphoglycan-LPPG
or glycoinosytolphospholipids-GIPL), and glycopeptides
(NETNES) (Macrae et al., 2005). Electron microscopy and
cryo-fracture have demonstrated that the vesicles come from
the plasma membrane of the protozoan and the flagellar pocket.
Recently, several surface proteins of the trans-sialidase, the
cruzipain and the mucin-associated surface proteins (MASPs)
families have been described in EVs, whose activity had
previously been related to the modulation of the immune
response by means of activating B cells and inducing a
Th17 response or processes of adherence and cell invasion
(Bermejo et al., 2011, 2013). Interestingly, MASPs are strongly
expressed in the parasite and present a high variability between
the different strains (Seco-Hidalgo et al., 2015). In recent
works, we demonstrated that EVs, circulating in patients with
CD, contained immature MASPs, with the presence of the
C-proximal and N-terminal regions (peptide signal) (De Pablos
et al., 2016; Díaz Lozano et al., 2017). MASPs are linked to the
membrane through glycosylphosphatidylinositol (GPI) anchors.
GPI participates in the inflammation processes that characterize
CD (Almeida and Gazzinelli, 2001). The immature MASPs
present in EVs (De Pablos et al., 2016; Díaz Lozano et al., 2017)
are recognized by antibodies from CD patients. They help the
parasite, in the presence of anti-T. cruzi antibodies, to evade the
immune response by inhibiting the activity of C3 convertase
and thereby impairing complement activation (Cestari et al.,
2012). Similarly, the EVs isolated from the sera of CD patients
are recognized both by the antibodies of the patients as well as
by the serum of mice infected with the parasite. Therefore, it has
been proposed that the immature MASPs in the outer side of the
membrane of these EVs can form immunocomplexes with the
IgGs of the patients (Díaz Lozano et al., 2017). In these studies,
we demonstrate the involvement of EVs in the inhibition of the
Frontiers in Microbiology | www.frontiersin.org 3 August 2019 | Volume 10 | Article 1854
fmicb-10-01854 August 13, 2019 Time: 16:5 # 4
Kemmerling et al. Review Congenital Chagas Disease
complement pathway, in which the terminal regions C- and
N- of the immature MASPs participate. We also show how the
antigens of the C- and N- immature regions of these MASPs
inhibit the complement by antigen competition, in the presence
of antibodies from CD patients. Besides, we identified differences
in antigen recognition of the EVs by sera from the patients,
depending on the pathology manifested by those affected by CD
(De Pablos et al., 2016; Díaz Lozano et al., 2017). These results
allowed us to consider T. cruzi EVs as markers of pathology,
suggesting that they play a role in the pathogeny of CD. Their
role in modulating the interactions between the parasite and the
placenta and the congenital transmission is under investigation.
However, preliminary results show that the parasite increases
placenta-derived exosomes in HPE (Castillo et al., 2017a). The
placenta is a rich source of exosomes which are related to
fetal-placental-maternal communication, fetal allograft survival,
and resistance to specific infections, among other functions
(Ouyang et al., 2014; Schorey and Harding, 2016). Therefore, it
is highly probable that placenta-derived exosomes play essential
roles during T. cruzi-host interplay.
PLACENTAL RESPONSES TO T. cruzi
The placenta is a temporary organ that separates the maternal
and fetal compartments throughout pregnancy (Arora et al.,
2017). The placenta is responsible for the metabolic exchange
between mother and fetus, and fulfills endocrine and immune
functions that ensure normal prenatal development of the fetus
and pregnancy-related changes in the mother (Liempi et al.,
2016; Arora et al., 2017). Mainly due to its regulatory role in the
maternal/fetal immune response, this organ is able to protect the
fetus against several pathogens (Delorme-Axford et al., 2014; Mor
et al., 2017) (see below).
The human placenta is a highly invasive (hemochorial)
chorioallantoic placenta. The functional units, where the
placental barrier is located, are the free-floating chorionic villi
formed by the trophoblast and the villous stroma. Maternal
blood surrounds and contacts the trophoblast in the placental
intervillous space (IVS). The trophoblast is a bi-stratified
covering epithelium composed of a superficial non-proliferative
syncytiotrophoblast (ST) and a proliferative germinal layer, the
cytotrophoblast (CT). The trophoblast is connected to and
separated from the villous stroma (VS), the fetal connective
tissue by a basal lamina, a specialized structure of extracellular
matrix (ECM) (Benirschke et al., 2012). Therefore, trophoblast,
basal laminae and VS, the latter containing fetal capillaries,
form the placental barrier that must be crossed by T. cruzi
in order to infect the fetus during trans-placental transmission
(Figure 1; Duaso et al., 2010; Carlier et al., 2012; Liempi
et al., 2016). Of note, T. cruzi displays a high tropism for the
decidual part of the placenta as compared to the heart, that
is likely related to the local immune environment [see further
and (Mjihdi et al., 2002)]. Also, in the placenta of mothers
of congenitally infected infants, only a few amastigotes can be
found in stromal cells such as macrophages, fibroblasts, and giant
cells while they are not or scarcely found in the trophoblast,
except in case of severe mortal cases of congenital infection
(Carlier and Truyens, 2015).
Since the trophoblast is the first placental tissue in contact with
the maternal blood, the ST is the first fetal cell layer exposed to
the parasite. It has been demonstrated that a high concentration
of T. cruzi trypomastigotes induces the destruction of the
trophoblast in ex vivo infected HPE (Duaso et al., 2010). However,
low parasite concentration induces cellular proliferation (Liempi
et al., 2016; Droguett et al., 2017) and differentiation (Liempi
et al., 2014, 2016) in the same placental tissue (see below).
The basal laminae, located between trophoblast and the fetal
connective tissue and around the fetal vessels are other structures
that T. cruzi needs to overcome (Duaso et al., 2010). T. cruzi can
bind to ECM molecules such as glycosaminoglycans, fibronectin,
and laminin (Lima et al., 2002) using surface molecules such
as gp85 (Maeda et al., 2014) and gp83 (Nde et al., 2006). The
VS, the placental fetal connective tissue, is also an important
obstacle for the parasite. The parasite presents several proteases,
among which the cruzipain has been proposed to be responsible
for collagen I destruction and disorganization in placentas from
mothers with chronic CD or in ex vivo infected HPE (Scharfstein
and Morrot, 1999; Castillo et al., 2012; Duaso et al., 2012;
Maeda et al., 2014). Matrix metalloproteinases (MMPs) such as
MMP-2 and MMP-9 are activated, and their expression levels
are increased in the presence of the parasite. Interestingly, if
these MMPs are inhibited, the parasite-induced damage in the
placental tissue is prevented, and the presence of parasite DNA
is decreased in ex vivo infected HPE (Castillo et al., 2012).
Importantly, the ECM forms a complex tridimensional network
with different types of elastic fibers and collagen molecules
including collagen I fibers, glycoproteins, and proteoglycans
(Duaso et al., 2010; Theocharis et al., 2019). Collagen I fibers
are the main components of the ECM, and if these molecules
are disorganized or destroyed, the 3D network of the ECM is
also disrupted, a fact that could facilitate the parasite’s motility
in the tissue, and its entrance into cells (Duaso et al., 2010).
Moreover, in vitro studies have shown that during parasite-ECM
interactions, the parasite changes its cytoskeletal conformation,
the state of protease activation and adapts its metabolism
(Mattos et al., 2019). In addition, parasite-induced ECM changes
modulate the presence of cytokines and chemokines, allowing
T. cruzi to manipulate and escape the innate and adaptive
immune responses (Marino et al., 2003). Studies performed in
CD patients with cardiac alteration have shown that T. cruzi
derived-antigens promote a differential expression of MMP-2
and MMP-9. There is a positive correlation between MMP-2 and
the immunomodulating cytokine IL-10, and a negative one with
the pro-inflammatory cytokine IL-1β, whereas MMP-9 showed a
negative correlation with IL-10. Therefore, it has been suggested
that MMPs and cytokines produced in the myocardium in
patients with CD are essential contributors to cardiac remodeling
(Medeiros et al., 2017). It would be interesting to study the
interactions between parasite-modulated MMPs and cytokines
in the placenta.
Another placental response to the parasite is the trophoblast
epithelial turnover. The epithelial turnover is part of the innate
immune system. Pathogens adhere to the plasma membrane
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FIGURE 1 | Human placental barrier. The human placenta is classified as a hemochorial chorioallantoic placenta. The placenta is composed of a fetal portion,
developed from the chorion frondosum, and a maternal portion, or basal decidua, which originates from the endometrium. The functional units, were the placental
barrier is located, are the free-floating chorionic villi formed by the trophoblast, and the villous stroma. Maternal blood surrounds and contacts the trophoblast in the
placental intervillous space. The trophoblast is a bi-stratified covering epithelium composed of a superficial non-proliferative syncytiotrophoblast (ST), and a
proliferate germinal layer, the cytotrophoblast (CT). The trophoblast is connected to and separated from the villous stroma (VS), the fetal connective tissue, and by a
basal lamina. The parasite present in the maternal blood (1), that comes in contact with the trophoblast in the intervillous space (2), must cross the placental barrier
in order to reach the fetal capillaries (3), and infect the fetus during transplacental transmission.
before invading host cells and, in case of a lining epithelium,
they adhere to the cells of the superficial cell layer which is
continuously removed. Therefore, the attached pathogens are
removed with the superficial epithelial cells (Liempi et al., 2016).
The trophoblast turnover implies precise orchestration of
different cellular processes: (i) cell proliferation of the CT, (ii)
cellular differentiation (referring to the incorporation of CT
cells into a non-replicative ST), and (iii) cell death by forming
apoptotic bodies (knots) in the ST that counterbalance the
proliferation of the CT cells. The apoptotic knots are released into
the IVS where the maternal blood circulates (Benirschke et al.,
2012; Mayhew, 2014; Liempi et al., 2016).
We have previously shown that T. cruzi induces the above-
mentioned cellular processes related to the epithelial turnover
in the trophoblast in both ex vivo infected HPE and in vitro
infected BeWo cells (trophoblastic cell line) (Duaso et al., 2011;
Liempi et al., 2014, 2016; Carrillo et al., 2016; Droguett et al.,
2017). Thus, T. cruzi increases DNA synthesis as well as cellular
proliferation markers such as PCNA (proliferating cell nuclear
antigen) (Liempi et al., 2016). In BeWo cells, the parasite
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also increases the percentage of cells in the S and G2/M cell
cycle phases and other commonly used proliferation markers
(AgNORs and Ki67) (Droguett et al., 2017). It is noteworthy
that PCNA modulates other cellular processes including DNA
repair, cell cycle, survival, and gene expression (Wang, 2014), and
that an increase of PCNA expression might occur in response to
T. cruzi-induced damage. Regarding trophoblast differentiation,
the parasite increases, in HPE and BeWo cells, the expression
and or secretion of the main biochemical markers, including
β-human chorionic gonadotropin (β-hCG) and syncytin (Liempi
et al., 2014, 2016). Additionally, in BeWo cells T. cruzi induces
cell fusion as demonstrated by the analysis of the re-distribution
of desmoplakin (intercellular adhesion protein) and by a two-
color fusion assay (Liempi et al., 2014). The parasite also
activates the ERK1/2 MAPK pathway (Castillo et al., 2013b),
one of the MAPK signaling pathways that mediate trophoblast
differentiation (Forbes and Westwood, 2010). Finally, the parasite
induces apoptotic cell death as part of trophoblast turnover
(Liempi et al., 2016). Indeed, T. cruzi activates in HPE a caspase
3 like activity, followed by DNA fragmentation and pyknosis
(Duaso et al., 2011). These data indicate that T. cruzi can boost
all steps of the turnover of chorionic trophoblasts. Interestingly,
a relation exists in trophoblasts between the cellular processes
related to apoptosis and their differentiation (Gauster et al.,
2009a,b). This is through caspase 8, a caspase operating upstream
the pro-apoptotic caspase 3. Caspase 8 is transiently activated
in CT cells just before their fusion into ST and is an essential
protein in the process of formation of the ST barrier (Huppertz
and Borges, 2008). We observed that T. cruzi infection increases
the expression and activation of caspase 8 in BeWo cells as well
as in HPE (Duaso et al., 2011; Carrillo et al., 2016). This fact
might favor the integrity of the ST barrier as well as limit parasite
entrance into ST (by favoring its turnover). Also, we showed
that caspase 8 can slow down intracellular parasite multiplication
(Carrillo et al., 2016), pinpointing caspase-8 activity as part of the
trophoblast cell defense mechanisms against T. cruzi infection.
Altogether, these results suggest that the trophoblastic response to
T. cruzi may be a mechanism that reduces the risk of congenital
transmission of the parasite. On the other hand, caspase 8 has
recently been disclosed to display pro-inflammatory effects, by
optimizing the cytokinic response to TLRs and by being able to
activate the cytokine IL-1β (Lawlor et al., 2017). We speculate that
such pro-inflammatory action causes placental lesions, favoring
the trans-placental passage of T. cruzi.
As mentioned above, the placenta is an immune regulatory
organ that modulates fetal as well as maternal immune responses
(Mor et al., 2017). Pathogens are recognized by pattern
recognition receptors (PRRs), including Toll-like receptors
(TLRs). Activation of those PPRs results in the secretion of
cytokines and chemokines aiming to fight infections (Janeway
and Medzhitov, 2002). The human trophoblast expresses all ten
of the known functional TLRs (Koga et al., 2009). T. cruzi is
recognized by TLR-2 and TLR-4 (present at the cell surface) as
well as the endosomal TLR-7 and TLR-9 (Tarleton, 2007; Gravina
et al., 2013; Castillo et al., 2017b). We have shown, in HPE,
that T. cruzi infection induces protein expression and activation
of TLR-2, but not of TLR-4 and TLR-9 (Castillo et al., 2017b).
T. cruzi induces the secretion of IL-1β, IL-6, IL-8, IL-10,
and TNF-α in HPE (Castillo et al., 2017b). Of note is that
secretion of IL-1β, IL-6, and TNF-α have been associated, within
the trophoblast, with cellular proliferation, and differentiation
(Haider and Knöfler, 2009; Hamilton et al., 2012). Interestingly,
the inhibition of TLR-2 impairs trophoblast turnover and
increases parasite infection (Castillo et al., 2017c). However, to
date we do not know if cells other than trophoblasts, such as
macrophages in the VS, are also involved in TLR activation.
However, our results allow us to propose TLR-2 initiated cytokine
profile as a local placental defense mechanism.
TRANSCRIPTOMIC STUDIES IN
PLACENTAS IN RESPONSE TO T. cruzi
INFECTION
The global placental transcriptomic response to T. cruzi infection
has also been studied. This approach allows us to study the gene
expression profiles during infection, allowing the identification of
new genes and/or pathways implicated in the establishment of the
infection and pathogenesis. The RNA-seq study has been carried
out in placentas obtained from term deliveries in T. cruzi-infected
and non-infected women. Forty-two differentially expressed
genes (DEGs) were identified, and gene-set association analysis
was performed to detect pathways linked to parasite infection. It
showed, not surprisingly, that the inflammatory and the immune
responses were upregulated in infected placentas while the anti-
inflammatory cytokine IL-38 (formerly IL-1 family member
10-IL1F10) (Garraud et al., 2018) was under-represented (Juiz
et al., 2018). Placental inflammation is in line with other reports
showing that: (i) newborns of T. cruzi-infected mothers are
prone to produce higher levels of pro-inflammatory cytokines in
comparison to those born to non-infected mothers (Vekemans
et al., 2000), (ii) T. cruzi infection of pregnant women affects
the developing immune system of fetuses independently of
congenital infection (Dauby et al., 2009), which might be related
to placental inflammation (Jennewein et al., 2017), and (iii)
the parasite induces, as mentioned above, in ex vivo infected
HPE, a highly significant increase of pro-inflammatory and
immunomodulatory cytokines (Castillo et al., 2017b,c).
Analysis of DEGs also suggests that the placental
inflammation might be counter-regulated in infected mothers.
For instance, placentas from infected women displayed
lower expression of genes related to exocytosis pathways
and neutrophil degranulation, probably limiting damages
associated with inflammation. Moreover, the expression of the
immunomodulatory HLA-G was increased (Juiz et al., 2018).
HLA-G is responsible for the generation of immunological
tolerance during gestation by inducing regulatory T cells and
tolerogenic dendritic cells (Carosella, 2011; Ferreira et al., 2017)
and might increase susceptibility to infections. Hence, in malaria,
increased levels of HLA-G in infected mothers are associated with
an increased risk to acquire malaria during infancy (Sadissou
et al., 2014). S100A14 is another interesting parasite-modulated
gene, that is downregulated in placentas from women with CD.
This gene codes for a member of the S100 protein family that
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regulates cell cycle progression, cellular differentiation, and
triggers an inflammatory response by engaging the receptor
for advanced glycation end products (RAGE) (Jin et al., 2011).
Interestingly, this same protein, S100A14, is reported to increase
the expression of the collagenase MMP2 (Chen et al., 2012; Qian
et al., 2016), which as explained above regulates parasite infection.
This might be in line with the observation that mutations on
the MMP2 gene favor congenital T. cruzi transmission (see
hereunder). On the other hand, PRG2 a gene that encodes the
precursor form of the eosinophil major basic protein (proMBP)
is an upregulated DEG in T. cruzi-infected placentas. MBP can
participate in the extracellular killing of parasites in the absence
of antibodies (Nakhle et al., 2018). Another important function of
MBP in the placenta is the inhibition of the pregnancy-associated
plasma protein A (PAPPA) (Weyer and Glerup, 2011), whose low
levels are associated with intrauterine growth restriction (Albu
et al., 2014). Therefore, overexpression of the PAPPA inhibitor
in the placenta of women with CD might also play a role in the
congenital transmission of T. cruzi.
Other, DEGs observed in placentas from seropositive women
and related to pregnancy were the genes CGB5 and KISS1,
which encode for hCG and kisspeptin, respectively. Both genes
were downregulated, and low serum levels of both proteins have
been proposed as markers of miscarriage (Jayasena et al., 2014).
Low KISS1 expression is associated with recurrent pregnancy
loss as well as preeclampsia and intrauterine growth restriction
(Armstrong et al., 2009; Park et al., 2012). In contrast, the DEG
TAC3 gene [encoding neurokinin B (NKB)] was upregulated
in placentas from seropositive women. NKB overexpression in
the trophoblast is associated with a decreased blood flow to
the placenta and increased vasoconstriction in the endometrium
and therefore related to preeclampsia (Familari et al., 2017).
Interestingly, NKB and kisspeptin have a role in hCG placental
expression in response to estradiol (Oride et al., 2015) and hCG,
as described above, is induced by T. cruzi in HPE and BeWo cells
(Liempi et al., 2014).
A microarray-based transcriptomics study carried out in
ex vivo infected HPE (Castillo et al., 2018), corroborates most
data obtained by RNA-seq in whole placentas (Juiz et al., 2017,
2018) as well as the T. cruzi-invasion mechanisms in HPE.
Genes that are involved with ECM remodeling are upregulated,
in concordance with our previous findings that demonstrate
the parasite-induced expression and activation of MMP-2 and
MMP-9 (Castillo et al., 2012). The changes in gene expression
regarding signal transduction pathways were also confirmed
(Castillo et al., 2013b, 2017b). Genes involved in innate immunity
were overexpressed, including CD46 and C1q that regulate or
form part of the complement system. Upregulation of C1q might
have an impact since it binds the T. cruzi calreticulin, thereby
enhancing the infection (Castillo et al., 2013a). On the other
hand, TLR-7 and TLR-8 are mainly increased while TLR-2,
whose inhibition favors infection and tissue damage (Castillo
et al., 2017c), appeared not to be upregulated in the microarray
analysis. Another contradictory observation was that a high
T. cruzi concentration decreased IL-6 expression more than 60-
fold as compared to control non-infected explants, whereas no
changes were observed when HPE were infected with a low
parasite concentration. On the other hand, mRNA expression
analysis showed a higher level of transcription, suggesting that
regulation of IL-6 could occur at post-transcriptional stages
(Castillo et al., 2017c).
Furthermore, similar to the study in whole placentas,
the majority of overexpressed genes were related to fetal
development and pregnancy-related processes, particularly
GH2, CSH1, and CSH2 genes that encode the pregnancy-
specific beta-1-glycoproteins growth hormone 2, chorionic
somatomammotropin hormone 1 and 2, respectively.
Another microarray-based study was done in placental tissues
from C57Bl/6J mice chronically infected with two distinct
T. cruzi strains (VD and K98, see above) (Juiz et al., 2017)
A total of 247 DEGs were identified between infected and
non-infected mice: 140 and 107 genes were up- and genes
downregulated, respectively, compared to non-infected mice.
Placentas infected with the VD parasites showed a higher
number of DEGs compared to the K98 infected ones (211
vs. 89 DEGs). There were DEGs common to both infected
groups and specific ones for each infected group; while 69%
(59/89) of genes were downregulated by K98 infection, VD
infection produced this response only in 39% (83/211) of
genes. Analysis of DEG networks by GeneMANIA showed that
the “Secretory Granule” pathway was downregulated in both
infected groups, whereas “Response to Interferon-gamma” as
well as “Innate Immune Response” pathways were upregulated
only in placental tissues infected with VD. This is interesting
since, as said above, the K98 strain displays poor placental
tropism and no congenital transmissibility, contrary to the VD
strain. It suggests the role of placental inflammation in the
process of congenital transmission. Another analysis that detects
small changes in predetermined gene sets (Gene-Set Enrichment
Analysis algorithm) showed downregulation of genes involved
in transcription, macromolecular transport, and metabolism in
infected placentas and upregulation of genes regulating signal
transduction pathways. Genes regulating apoptotic cell death
were downregulated in the murine placentas infected with both
parasite strain.
These transcriptomic analyses identify a gene expression
profile in the placentas from T. cruzi- seropositive mothers that
are different from those from seronegative women. It globally
shows that affected genes are involved in cell adhesion, cellular
proliferation and differentiation, apoptosis, vesicle transport
processes, ECM organization, lipid and protein metabolism, and
the inflammatory/immune responses.
FAMILY CLUSTERING OF CONGENITAL
TRANSMISSION OF T. cruzi INFECTION
AND SNPs
It is still unknown why some infected mothers transmit the
infection in successive gestations to their babies while others
do not, leading to family clustering of congenital transmission.
A case-control study of single-nucleotide polymorphisms (SNPs)
located within human loci encoding different proteins expressed
in placental tissues was performed using genomic DNA
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from clinical samples of 116 non-infected children born to
seropositive women and children with congenital T. cruzi
infection. Logistic regression analysis showed that susceptibility
of congenital infection was associated with SNPs in sites
rs243866, rs17859821, and rs2285053from MMP2 gene and
rs11244787 and rs1871054 sites from the ADAM 12 locus.
In case of MMP2 rs243866 and rs17859821 positions, one
or both copies of the mutant allele (Adenine) increased the
likelihood of congenital infection, whereas, for rs2285053, both
T alleles are needed for susceptibility to infection. Mutation in
rs2285053 interrupts a CCACC box promoter site (Sp1-type)
causing a weaker activity of the promotor. The rs243866 position
is located upstream of a half-palindromic potential estrogen
receptor binding site (Harendza et al., 2003). Both rs243866
and rs2285053 mutant alleles reduce the transcription activity
of MMP2, which in turn modulate the ECM-remodeling and
immune responses, and thus the susceptibility to infection.
ADAM12 belongs to the ADAM protein family; it is a membrane-
bound MMP-protease with a role in cell-cell and cell-matrix
interactions that are associated with muscle development,
fertilization, neurogenesis inflammatory, and immune responses.
In preeclampsia (Grill et al., 2009) and ectopic pregnancy (Rausch
and Barnhart, 2012), among other disorders related to pregnancy,
ADAM 12 plasmatic concentrations are altered. Also, ADAM 12
promotes the transforming growth factor β (TGF-β) signaling
activation leading to transcriptional activation. Importantly,
TGF-β activation increases host cell susceptibility to T. cruzi
infection (Ming et al., 1995; Hall and Pereira, 2000).
Various other SNPs have been related to the susceptibility
to T. cruzi infection and progression of CD. Particularly, genes
encoding cytokines/chemokines involved in inflammatory and
immune response have been proposed as biomarkers (Calzada
et al., 2009; Torres et al., 2010; Pissetti et al., 2011; Flórez
et al., 2012; Nogueira et al., 2015; Furini et al., 2016; Ferreira
et al., 2018). Thus, TGF-β1 polymorphism, mainly CT and TT
genotypes at position – 509 of the TGFB1 gene have been
associated with the susceptibility of acquiring CD in a Brazilian
population (Ferreira et al., 2018). The same genotype, in addition
to the genotypes −988 C/A; −800 G/A; −10 T/C; and 263 C/T
has been studied in the Colombian and Peruvian populations.
In this study, the genotype 10 C/C was increased in the group
of CD patients of both populations and has been proposed to be
involved in differential susceptibility to T. cruzi infection (Torres
et al., 2010). Another important pro-inflammatory cytokine
involved in CD is TNF-α. The TNF- α gene is located in the MHC
locus, and its polymorphism is associated with many infectious
diseases, including parasitic ones. TNF-α is increased in the
hearts of patients with chronic chagasic cardiomyopathy and
is associated with tissue damage. An association was observed
between the absence of the TNF-238A allele and negative serology
for CD. Seropositive individuals carrying the TNF-238A allele
produced significantly higher TNF-alpha levels than healthy ones
and therefore the TNF-α polymorphism at position−238 has also
been associated to the susceptibility to T. cruzi infection and CD
progression (Pissetti et al., 2011). Other SNPs in genes encoding
for cytokines and molecules involved in the immune response
has been related to CD, including interferon (IFN)-γ (-874 T/A)
(Torres et al., 2010) and IL-18 (rs2043055 polymorphism) (Flórez
et al., 2012; Nogueira et al., 2015), RANTES, and chemokine
receptors CCR2 and CCR5 (Flórez et al., 2012). It would thus be
worthwhile to also investigate such polymorphisms in the context
of congenital transmission of T. cruzi.
MATERNAL T. cruzi SYSTEMIC IMMUNE
RESPONSE, GESTATION, AND
CONGENITAL INFECTION
The immune system during pregnancy is characterized by
a subtle balance between immune tolerance and activation.
Regulatory T cells are increased during pregnancy in order
to avoid fetal rejection. Indeed, the maternal immune cells
recognize paternal antigens expressed by the trophoblast and
other fetal cells crossing the placenta to the maternal circulation.
The mechanisms leading to this regulatory environment have
been largely described elsewhere (Aluvihare et al., 2004; Racicot
et al., 2014). Maternal immune tolerance is fundamental to
a successful pregnancy. It does, however, not mean that the
pregnant women are unable to mount immune responses, and
trophoblasts possess multiple ways to escape immune attack
(Straszewski-Chavez et al., 2004). Besides, immune responses
during gestation are, except for the periods of implantation,
placentation, and parturition, physiologically oriented toward a
Th2-type. It likely aims to protect the uteroplacental unit and the
fetus against harmful inflammation (Mor et al., 2017). Whereas
the regulatory and Th2-biased environments are particularly
pronounced at the level of the UPU, it may also impact peripheral,
and systemic immune responses (Reinhard et al., 1998).
Trypanosoma cruzi infection induces a complex immune
response. The control of T. cruzi infection relies on diverse
effector mechanisms needed to fight both extracellular
trypomastigotes and intracellular amastigotes. Therefore,
IFN-γ, cytotoxic cells, and antibodies (Abs) all play a role in
the control of the infection [reviewed in Truyens and Carlier
(2017)]. Antibodies potentially participate in extracellular
parasite elimination mainly by inducing complement-dependent
and independent lysis of parasites and phagocytosis of opsonized
parasites. IFN-γ, initially produced by NK cells, then by both
CD4 + Th1 and CD8 + T cells, is a significant player in the
immune responses against intracellular pathogens (Kak et al.,
2018). It activates among other the microbicidal properties of
phagocytes, mainly macrophages, allowing them to limit and/or
kill the intracellular parasites. Infected cells can be killed by
cytotoxic CD8 + T cells while the cytotoxic action of NK cell
on T. cruzi-infected cells is likely not significant (Truyens and
Carlier, 2017). The cellular response to T. cruzi is thus mainly
Th1-oriented. Our studies in mice show that this inflammatory
immune response has serious harmful effects on gestation when
the host is in the acute phase of infection. Indeed, acute infection
impedes reproduction, related to either infertility induced by
the infection (inhibition of cell division of the embryo before
implantation) or fetal loss occurring along gestation, due to
massive placental invasion by parasites. Chronic maternal
infection does not affect reproductive capacity but induces
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reversible fetal growth retardation (Carlier et al., 1987). Such
deleterious effects did not rely on congenital infection but were
associated with increased production of TNF-α (Rivera et al.,
1995; Mjihdi et al., 2002). In humans, most women of gestational
age have a chronic infection (see above). We have similarly
observed that T. cruzi-infected women give birth to newborns
with low birth weight, in the absence of congenital infection
more frequently (Torrico et al., 2004).
Besides, in the absence of congenital transmission, several
data indicate bidirectional and opposite interactions between
the immune response to T. cruzi and the immune environment
of gestation. On one side, pregnancy dampens and modifies
the immune response to T. cruzi. Indeed, we found that blood
cells from chronically infected pregnant women released, on
average, two to threefold less IFN-γ and IL-2 in response to
non-specific lymphocyte stimulants (PHA and LPS) than non-
pregnant women (Hermann et al., 2004). They also produced,
on average, sevenfold less IL-10. Accordingly, lower levels of IL-
10 and IFN-γ were detected in the serum of pregnant infected
women than in non-pregnant infected ones (Cardoni et al.,
2004). This shows that pregnancy reduces the global capacity of
their lymphocytes to be activated (though it is not completely
inhibited), likely as a result of the relative immunosuppression
associated with gestation. Also, the cytokine profile moved
toward a more inflammatory environment in infected pregnant
women, since the capacity to produce the inflammatory cytokine
IFN-γ was less inhibited during pregnancy than the capacity
to produce IL-10 (an anti-inflammatory cytokine), being in line
with the inflammatory transcriptome detected in the placenta of
T. cruzi-infected women [see above (Juiz et al., 2018)]. On the
other hand, Egui et al. recently observed in a murine experimental
T. cruzi infection model that chronic infection reduced the
expression of gestation-induced inhibitory receptors on T cells
(CTLA4 on CD4 + and CD8 + T cells and CD160 on CD8 + T
cells), suggesting that T. cruzi chronic infection counteracts
the immunosuppression associated with gestation but does not
impact the gestation outcome (Egui et al., 2017).
Our previous studies in pregnant chronically infected women
showed that gestation also reduced the specific IFN-γ response
to parasite antigens as compared to the response of non-pregnant
infected ones (Hermann et al., 2004). This was the case for women
that transmitted (T mothers) as well as those that did not transmit
(NT mothers) the parasite to their fetus. Strikingly, this specific
IFN-γ response was markedly lower in T than NT mothers and
was associated with less activated monocytes (Hermann et al.,
2004). On the other hand, we and others have reported that the
circulating parasite load is slightly increased during the second
and third trimester of pregnancy (Brutus et al., 2010; Siriano et al.,
2011). Moreover, T mothers displayed higher parasitemia than
NT ones (Hermann et al., 2004; Kaplinski et al., 2015). IFN-γ is
well known as a key factor in the control of T. cruzi infection
(Truyens and Carlier, 2017). These data strongly suggest that
the increase of parasite burden in T mothers results from a
reduced control of the infection and points to a central role of
parasite burden as a risk factor of congenital transmission. In line
with this, several studies underline that congenital transmission
occurs mostly in mothers displaying blood parasites amounts that
are detectable by PCR (i.e., PCRs are generally negative in NT
mothers). The microbial burden is also a key factor of congenital
transmission of other pathogens (Lilleri and Gerna, 2017).
The increase of parasite burden during gestation likely
results from the relative immunosuppression associated with
gestation, while the increased parasite load in T mothers
probably relates to their more depressed IFN-γ response. The
question is, thus, why T mothers display such feature? Several
factors may be considered, concerning the parasite, the host, or
epidemiological parameters. Living in endemic countries where
vectorial transmission occurs may lead to frequent reinfections.
Multiple infections, though leading to transiently increased
parasite levels, result in lower parasitemia in the long term, the
hypothesis being that repeated antigen exposure reinforces the
Th1 response that controls the parasite (Machado et al., 2001;
Bustamante et al., 2007; Kaplinski et al., 2015). In line with
this, it was observed that higher vector exposure of women
living in endemic countries decreases the risk of congenital
transmission (Sánchez Negrette et al., 2005; Kaplinski et al.,
2015). Congenital transmission rates are also lower in non-
endemic countries (2.7%), free of vectorial reinfections, than in
endemic countries [2.7% vs. 5%, respectively (Howard et al.,
2014)]. Parasite load may also vary according to the parasite
genotype/strain (Moreira et al., 2013).
Our data also suggest that host factors modulate the risk
of congenital transmission of T. cruzi. Genetic and epigenetic
factors may influence the efficacy of immune responses against
pathogens and consequently modulate the microbial load (Möller
et al., 2018). For instance, polymorphism of genes encoding
proteins of the axis IL-12-IFN-γ and genetic variations affecting
the modulatory action of long non-coding RNAs or micro-RNAs
are reported to impact diseases (Vannberg et al., 2011; Duval
et al., 2017; Gao and Wei, 2017; Ellwanger et al., 2018). We
compared the ability of T and NT women to produce IFN-γ
to T. cruzi and mitogens several months after they had given
birth, i.e., in the absence of the immunosuppression of pregnancy
(Hermann et al., 2004). We found that T women still displayed a
more depressed ability to produce this cytokine than NT women,
suggesting that inherent host factors involved might be genetic.
Likewise, we have recently reported that several genes related to
the immune system were differentially expressed in the placenta
of T and NT mothers as well as an association between congenital
T. cruzi transmission and the presence of polymorphism among
some gene expressed in the placenta (see above) (Juiz et al., 2016,
2018). Of note, differential immune responses associated with
the congenital transmission of other pathogens have also been
recently reported (Lilleri and Gerna, 2017; Wujcicka et al., 2018).
Besides, epigenetic modulation may also have occurred in some
women in relation either with the T. cruzi strains present in the
host or to their history of infections with other pathogens (Gomez
et al., 2013; Smith and Denning, 2014).
Finally, we and others noticed that T mothers were younger
and had a lower mean number of previous pregnancies
than the NT mothers (Hermann et al., 2004; Kaplinski
et al., 2015), which might be related to the immuno-
enhancing effect of multiparity on the maternal immune system
(Skowron-Cendrzak et al., 1999).
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NEONATAL IMMUNE RESPONSE TO
T. cruzi
Immune responses in early life are physiologically different from
adult responses. Similarly, to what occurs during pregnancy,
the neonatal immune system is characterized by a certain
degree of immunodeficiency and weak Th1 but excessive Th2
responses, contributing to high susceptibility to pathogens
and the development of suboptimal immune responses to
vaccines administered in early life. However, the mechanisms
leading to immunodeficiency and Th2 bias are completely
different from those activated during pregnancy and have
been reviewed elsewhere (Levy, 2007; PrabhuDas et al., 2011;
Elahi et al., 2013). Mechanisms responsible for the regulatory
environment comprises, among others, impaired signaling
pathways downstream of Toll-like receptors 3 and 4, the presence
of higher circulating levels of adenosine, the presence of higher
numbers of regulatory T cells, and the presence of particular
inhibitory “erythroid cells.” The Th2 bias results from the
hypermethylation of the IFNG gene, while the Th2 locus is
hypomethylated. Also, the proliferation of Th1 T cells in early life
is strongly hindered due to the expression of a particular receptor
for IL-4 produced by Th2 T cells. Engagement of this receptor
induces apoptosis of Th1 cells.
Our studies in humans, performed in infants from chagasic
mothers, point out that T. cruzi infection triggers neonatal type
1 immune responses, overcoming the physiological immune
deficiency associated with early life (Hermann et al., 2002).
Indeed, CD8+ T cells, and CD4+ T cells to a lesser extent, were
activated in T. cruzi congenitally infected new-borns to an adult-
like level and produced IFN-γ. Besides, their NK cells display
phenotypic and functional alterations suggestive of a previous
in utero activation when parasites were transmitted from the
mother (Hermann et al., 2006). It also pinpoints the imprinting
of the maternal T. cruzi infection on the neonatal immune
system, revealing an immuno-stimulatory/adjuvant property of
the parasite, as both congenitally infected and uninfected infants
from chagasic mothers responded more strongly to vaccines
directly administered during the first 6 months of life, like
those against BCG, hepatitis B, tetanus, and diphtheria (Dauby
et al., 2009). In trying to decipher the mechanisms allowing
the parasite to induce type 1 immune responses in early life,
we showed that the parasite could strongly activate neonatal
NK cells to produce IFN-γ, known to drive Th1 type responses
rapidly. NK cell activation by T. cruzi is indirect and depends
on cross-talk with monocytes (and not with dendritic cells), on
IL-12 synthesis and engagement of TLR2, 4, 7, and 9 (Guilmot
et al., 2013). The parasite also very efficiently licensed neonatal
dendritic cells to activate CD4+ and CD8+T cells. Interestingly,
DC and monocyte activation by T. cruzi is reinforced in the
presence of maternal IgG isolated from cord blood samples from
neonates born to NT infected mothers, i.e., carrying T. cruzi-
specific IgG (Rodriguez et al., 2012). These observations allow
us to make the hypothesis that monocytes, likely activated in
fetuses from infected mothers combined with the maternally
transmitted T. cruzi – specific antibodies might allow the fetus
to fight parasites and maybe in some cases to eliminate them if
only a few parasites were transmitted.
FINAL REMARKS
Some relevant questions regarding the role of parasite diversity,
host genetic response, and host immune responses deserve
further investigations. The study of gene expression profiles
during infection constitutes a powerful tool to analyze global
responses of several kinds of cells and tissues, allowing the
identification of new genes and/or pathways implicated in the
establishment of the infection and pathogenesis as well as possible
local tissue responses. Other aspects such as the role of maternal
microbiomes in the likelihood of vertical transmission of T. cruzi
have not been investigated yet.
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